Daré Bioscience, Inc.
DARE
$1.92
$0.073.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.02M | -13.40M | -17.46M | -18.60M | -1.68M |
| Total Depreciation and Amortization | 2.03M | 1.65M | 1.12M | 651.80K | 207.10K |
| Total Amortization of Deferred Charges | -17.50K | -17.50K | 96.50K | -27.80K | -700.00 |
| Total Other Non-Cash Items | 2.20M | 2.09M | 2.44M | 2.53M | 2.65M |
| Change in Net Operating Assets | -2.13M | -210.70K | 7.78M | 3.94M | 5.64M |
| Cash from Operations | -9.94M | -9.89M | -6.02M | -11.51M | 6.82M |
| Capital Expenditure | -227.90K | -385.20K | -741.40K | -284.40K | -723.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -227.90K | -385.20K | -741.40K | -284.40K | -723.00K |
| Total Debt Issued | 486.70K | 486.70K | 486.70K | 561.70K | 561.70K |
| Total Debt Repaid | -2.71M | -1.82M | -1.48M | -1.02M | -566.00K |
| Issuance of Common Stock | 20.59M | 20.93M | 19.71M | 966.70K | 674.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 297.20K | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -347.70K | -321.70K | -79.60K | -80.00K | -83.30K |
| Cash from Financing | 18.32M | 19.28M | 18.64M | 427.90K | 587.10K |
| Foreign Exchange rate Adjustments | 38.60K | 7.20K | -33.30K | -17.30K | -15.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.19M | 9.01M | 11.84M | -11.38M | 6.66M |